ArticleProceedings (Baylor University. Medical Center)2025
Characteristics and outcomes of observed versus resected pancreatic neuroendocrine tumors.
Article in Proceedings (Baylor University. Medical Center), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Pancreatic neuroendocrine tumors: studying real-world outcomes.Proceedings (Baylor University. Medical Center) · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Pancreatic neuroendocrine tumors (pNETs) are a rare group of tumors with a wide range of clinical presentations. pNETs may present as incidentally discovered slow-growing tumors or as more aggressive tumors with metastatic potential. The mainstay of treatment is surgical resection; however, some have argued that observation can be considered for small, nonfunctional tumors. The objective of this study was to compare patients with pNETs who underwent initial resection versus observation to better understand tumor characteristics that favor either treatment approach. Methods: A retrospective review was performed of patients diagnosed with pNETs at a tertiary referral center from 2018 to 2023. Information on the patient and tumor, disease and treatment course, and outcomes was collected. Results: Forty-three patients were included in the study; 33% underwent initial resection, 37% underwent observation, and 30% underwent surgical resection following a period of observation (delayed resection). Patients who underwent initial resection were more likely to be younger with fewer comorbidities and have symptomatic or functional tumors. Patients with tumors >2 cm were more likely to have a postoperative complication. In a subgroup of patients with incidentally discovered tumors ≤2 cm, 33% underwent delayed resection and did not experience any postoperative complications; 66% underwent observation, and none had progression of their disease over the follow-up period of 17 months. Conclusion: While surgical resection remains the mainstay of treatment for pNETs, a period of observation in select individuals with small, incidentally discovered pNETs may also be considered safe. Management with surgical resection or initial observation must be an individualized decision and may be optimally supported with formal multidisciplinary tumor board discussion.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.